Atlas market file · Equity · United States
ACM Research, Inc.ACMR
- Last close
- 78.98
- Change
- -1.15%
- 96-bar range
- 37.16 – 127.19
- As of
- 6 Aug 2026
ACM Research, Inc. is a special industry machinery, nec issuer listed as ACMR on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+305.23% over the window).
Source rail: Yahoo Finance chart API (ACMR). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for ACMR. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
ACMR public profile
Special industry machinery, nec issuer. ACM Research, Inc. is connected to current market context, cited company sources and its retained research file.
ACM Research, Inc. trades as ACMR on NASDAQ. ACM Research, Inc. (ACMR) has a latest verified close of 78.98, down 1.15%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files ACMR under USA Stocks and Science & Biotech Stocks for browsing.
What changed for ACM Research, Inc. today
ACM Research, Inc. (Nasdaq: ACMR) is a Fremont, California-based supplier of single-wafer wet processing tools used in semiconductor manufacturing, with a product line that includes advanced systems for wafer-level packaging (WLP) such as coating, plating, stripping, and etching systems. The company’s tools are marketed to foundries and advanced packaging houses, where precision and throughput are non-negotiable. ACMR’s filing traffic on SEC EDGAR shows a company with a $3.07 billion balance sheet, $872.3 million in cash, and $1.58 billion in shareholders’ equity, but also a quarterly operating cash outflow of $-29.5 million and a $29.5 million inventory build-a coincidence that smells less like just-in-time logistics and more like just-in-case overstocking.
On the corporate governance side, ACMR’s board has spent the last few weeks approving the mechanics of an H-share offering in Hong Kong, proposing to issue shares representing up to 7% of its total share capital. The 8-K filed on 29 May 2026 notes that the board’s approval is “subject to approval by its shareholders,” a phrase that usually precedes either a capital raise or a management desks power grab. The filing stops short of explaining why now, how much capital is sought, or how dilution will be priced, leaving shareholders to parse the optics against the balance sheet.
For the quarter ended 31 March 2026, ACMR reported revenue of $231.3 million, net income of $17.3 million, and diluted EPS of $0.24 on 69.8 million diluted shares. Operating income stood at $36.2 million, while R&D spend clocked in at $36.5 million-nearly erasing operating income and hinting at a business that’s still investing heavily in the next generation of tools. Inventory rose to $738.0 million, up $29.5 million from the prior quarter, raising the question of whether demand is accelerating or the company is simply stockpiling inputs in a chip-cycle that remains notoriously hard to call. Short-term investments of $34.7 million sit on the asset side, while liabilities total $982.4 million, leaving a net cash position that looks healthy on paper but less so when cash flow turns negative. Capital expenditures for the quarter were $22.2 million, a figure that suggests ACMR is still building out capacity even as free cash flow lags.
ACMR’s product rail is anchored in wafer-level packaging, a segment where the company positions itself as a specialist in advanced wet processing tools. The company’s WLP systems page illustrates the hardware, but the filings do not provide breakdowns of revenue by product line, customer concentration, or end-market mix, leaving investors to infer performance from topline and inventory trends. The absence of segment data or geographic revenue splits in the 10-Q means the market must take ACMR’s wafer-level packaging story on trust, at least until the next filing cycle.
The company’s cash generation remains a talking point: despite $872.3 million in cash and equivalents, operating cash flow was negative $-29.5 million, a gap that the 10-Q attributes to working capital movements rather than fundamental cash-burn. The board’s H-share listing proposal, meanwhile, is the most concrete development in months, though its financial impact is unspecified. Until ACMR files a follow-up 8-K or 6-K detailing the size of the H-share offering, the motive will remain a matter of interpretation. The inventory build and negative operating cash flow, however, are facts, not interpretations, and they sit at the center of the story for now.
For readers tracking ACMR, the tension is simple: the balance sheet is strong, the product line is credible, but the cash-flow math is weak and the governance filings are light on detail. The next catalyst isn’t a stock chart-it’s a filing that explains what the H-share listing is for, how much capital it will raise, and whether the inventory build is demand-led or a bet against a chip-cycle slowdown. Until then, ACMR looks like a company with its wallet open but its cash flow under the weather.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
ACMR technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on ACMR
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep ACMR research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
ACMR FAQ
What is ACM Research, Inc. (ACMR)?ACM Research, Inc. (ACMR) has a latest verified close of 78.98, down 1.15%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed...
ACM Research, Inc. (ACMR) has a latest verified close of 78.98, down 1.15%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for ACMR?ACM Research, Inc. (ACMR) has a latest verified close of 78.98, down 1.15%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources,...
ACM Research, Inc. (ACMR) has a latest verified close of 78.98, down 1.15%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files ACMR under USA Stocks and Science & Biotech Stocks for browsing.
How often is the ACMR page updated?The ACMR public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The ACMR public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for ACMR?The ACMR file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:ACMR. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The ACMR file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:ACMR. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on ACMR?Yes. The workstation can open ACMR, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open ACMR, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this ACMR page investment advice?No. The ACMR page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The ACMR page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
ACMR
Equity · evidence first